title: Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib.
authors.affiliation: Department of Clinical Medicine and Surgery, Section of Endocrinology, Federico II University of Naples, Via S. Pansini 5, 80131, Naples, Italy, vinc.endo@libero.it.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Marotta
authors.forename: Carolina
authors.initials: C
authors.lastname: Di Somma
authors.forename: Manila
authors.initials: M
authors.lastname: Rubino
authors.forename: Concetta
authors.initials: C
authors.lastname: Sciammarella
authors.forename: Roberta
authors.initials: R
authors.lastname: Modica
authors.forename: Luigi
authors.initials: L
authors.lastname: Camera
authors.forename: Michela
authors.initials: M
authors.lastname: Del Prete
authors.forename: Francesca
authors.initials: F
authors.lastname: Marciello
authors.forename: Valeria
authors.initials: V
authors.lastname: Ramundo
authors.forename: Luisa
authors.initials: L
authors.lastname: Circelli
authors.forename: Pasqualina
authors.initials: P
authors.lastname: Buonomano
authors.forename: Annamaria
authors.initials: A
authors.lastname: Colao
authors.forename: Antongiulio
authors.initials: A
authors.lastname: Faggiano
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D000077157:Sorafenib; D000077210:Sunitinib; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D007457:Iodine Radioisotopes; D010671:Phenylurea Compounds; D011758:Pyrroles; D009536:Niacinamide; D000077157:Sorafenib; D000077210:Sunitinib